Mercer East, Mercer East, China.

China is an important part of Merck's global growth strategy. Merck China is headquartered in Shanghai, reporting directly to the US headquarters, with more than 5,000 employees. 20 1 1 year, Merck invested1500 million dollars to establish China R&D center in Beijing. 20/kloc-in April, 2003, Merck's new factory in Hangzhou, with an investment of 654.38+0.2 billion USD and an area of 75,000 square meters, was officially put into use. It is one of the most advanced and largest pharmaceutical production and packaging factories in China and even the Asia-Pacific region. Therefore, Merck has realized the integration of R&D, manufacturing and commercial operation in China, which better meets the needs of patients and the public in China.

Merck's Development in China

1992, Merck (China) co., ltd was established.

65438-0994, Hangzhou Merck Pharmaceutical Co., Ltd. was established-Merck and Hangzhou Huadong Pharmaceutical (Group) Company established a joint venture.

In 2005, Merck Laboratory set up a global clinical data management center in Beijing.

In 2009, Merck China merged with Schering-Plough China.

In 20 10, Merck laid the foundation stone for its new factory in Hangzhou Economic and Technological Development Zone.

On 20 1 1 year, Merck signed a cooperation agreement with the voice group. Merck signed a cooperation agreement with Chongqing zhifei Bio.

20 12, Xiansheng Merck (Shanghai) Pharmaceutical Co., Ltd. was officially put into production.

Merck East Asia R&D Headquarters and China R&D Center were established in Beijing.

20 13 The new factory in Hangzhou was put into operation. Merck (China) Investment Co., Ltd. was established.

In 20 15, Merck was selected as the "Top 20 Best Employers in China" by Aon Hewitt.

At present, Merck has 65,438+00 operation areas, factories and R&D centers in Chinese mainland * *, with nearly 5,000 employees.